Medigus' Subsidiary Revoltz Announces Pre-Orders for Innovative Micro Mobility EV - PORTO

Revoltz, a subsidiary of Medigus Ltd. MDGS, has opened pre-orders for its ground-breaking micro mobility electric vehicle, the PORTO EV, signaling a significant leap in the urban transportation sector. This move aligns with the company's commitment to innovation and sustainability, targeting eco-conscious consumers and city commuters looking for efficient and environmentally friendly transport solutions.

Introducing PORTO - A Revolution in Micro Mobility

The PORTO EV, which stands out for its compact design and advanced technology, is designed to ease the challenges of urban mobility. With features catered to enhance user experience and reduce environmental impact, PORTO is poised to be a favorite among those prioritizing green transport options. As pollution and traffic congestion continue to plague cities, the PORTO EV's entry into the market is timely.

Investment in Innovation

Medigus Ltd. MDGS has diversified its portfolio to include cutting-edge technologies across various sectors. The development of PORTO EV falls under the company's strategic investment in the advancing field of electric vehicles (EVs). As an Israel-based medical device company, Medigus has a broad market scope, producing and marketing endosurgical tools internationally, while also harnessing its technology to facilitate medical advancements.

How to Secure Your Pre-Order

Prospective customers can now secure their pre-order of the PORTO EV, ensuring early access to this highly anticipated micro mobility solution. Pre-orders signal trust and interest in Revoltz's vision for what urban transport can become, and customers lining up for the PORTO are part of this transformative movement in the EV space.

Investor Interest in Medigus and Future Mobility

Investors are keeping a close watch on Medigus MDGS and its associated companies, including Revoltz, as they explore innovative solutions that promise substantial growth in the EV micro mobility market. The opening of pre-orders for PORTO highlights a potential increase in demand that investors in First Day OTC FDOC might find particularly attractive.

Medigus, Revoltz, Pre-order